Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Labetuzumab> ?p ?o }
Showing triples 1 to 55 of
55
with 100 triples per page.
- Labetuzumab abstract "Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. This drug was developed by Immunomedics, Inc.".
- Labetuzumab atcPrefix "none".
- Labetuzumab casNumber "219649-07-7".
- Labetuzumab wikiPageID "9702969".
- Labetuzumab wikiPageLength "1639".
- Labetuzumab wikiPageOutDegree "7".
- Labetuzumab wikiPageRevisionID "640211177".
- Labetuzumab wikiPageWikiLink Carcinoembryonic_antigen.
- Labetuzumab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Labetuzumab wikiPageWikiLink Colorectal_cancer.
- Labetuzumab wikiPageWikiLink Humanized.
- Labetuzumab wikiPageWikiLink Humanized_antibody.
- Labetuzumab wikiPageWikiLink IgG1.
- Labetuzumab wikiPageWikiLink Immunoglobulin_G.
- Labetuzumab wikiPageWikiLink Immunomedics.
- Labetuzumab wikiPageWikiLink Monoclonal_antibody.
- Labetuzumab wikiPageWikiLinkText "CEA-Cide".
- Labetuzumab wikiPageWikiLinkText "Labetuzumab".
- Labetuzumab wikiPageWikiLinkText "labetuzumab".
- Labetuzumab atcPrefix "none".
- Labetuzumab casNumber "219649".
- Labetuzumab chemspiderid "NA".
- Labetuzumab hasPhotoCollection Labetuzumab.
- Labetuzumab kegg "D08936".
- Labetuzumab mabType "mab".
- Labetuzumab source "zu/o".
- Labetuzumab target Carcinoembryonic_antigen.
- Labetuzumab type "mab".
- Labetuzumab verifiedfields "changed".
- Labetuzumab verifiedrevid "458270329".
- Labetuzumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Labetuzumab wikiPageUsesTemplate Template:Drugbox.
- Labetuzumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Labetuzumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Labetuzumab subject Category:Monoclonal_antibodies_for_tumors.
- Labetuzumab hypernym Antibody.
- Labetuzumab type Article.
- Labetuzumab type ChemicalSubstance.
- Labetuzumab type Drug.
- Labetuzumab type Antibody.
- Labetuzumab type Article.
- Labetuzumab type Chemical.
- Labetuzumab type Drug.
- Labetuzumab type ChemicalObject.
- Labetuzumab type Thing.
- Labetuzumab type Q8386.
- Labetuzumab comment "Labetuzumab (marketed under the trade name CEA-CIDE) is a humanized IgG1 monoclonal antibody for the treatment of colorectal cancer. It selectively binds to carcinoembryonic cell adhesion molecule 5. This drug was developed by Immunomedics, Inc.".
- Labetuzumab label "Labetuzumab".
- Labetuzumab sameAs ليبيتوزوماب.
- Labetuzumab sameAs Labetuzumab.
- Labetuzumab sameAs m.02ppmvc.
- Labetuzumab sameAs Q3825147.
- Labetuzumab sameAs Q3825147.
- Labetuzumab wasDerivedFrom Labetuzumab?oldid=640211177.
- Labetuzumab isPrimaryTopicOf Labetuzumab.